 |
Articles: Drug/Product Approvals |
Prior Articles
FDA Approves EMBEDA for Management of Moderate to Severe Chronic Pain
King Pharmaceuticals, 08/14/09
Free full text
CryoLife Receives FDA 510 Clearance for SynerGraft Processed Human Cardiac Patch Material
Cryolife, 08/13/09
Free full text
Multaq (dronedarone) for Atrial Fibrillation Now Approved in Canada
Sanofi-aventis, 08/13/09
Free full text
Teva Announces Approval And Launch Of Oxaliplatin Injection
Teva Pharmaceutical Industries, 08/12/09
Free full text
Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex
Mylan, 08/11/09 Sepracor Announces New Drug Submission to Health Canada for STEDESA as Adjunctive Treatment for Epilepsy
Sepracor, 08/11/09 APP Pharmaceuticals Receives Approval for Idarubicin HCI Injection
American Pharmaceutical Partners, 08/11/09
Free full text
Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval
Cell Therapeutics, 08/11/09
Free full text
Dronedarone (Multaq): Benzofuran derivative approved to reduce the risk of CV hospitalization in patients with AF
Formulary, 08/10/09 FDA Approves New 3000 IU Vial Size for Kogenate FS, antihemophilic factor (recombinant)
Bayer HealthCare Pharmaceuticals, 08/10/09
Free full text
Afinitor approved in EU as first treatment proven to benefit patients with advanced kidney cancer after failure of targeted therapy
Novartis, 08/07/09
Free full text
Guiding Your Drug Name to Approval
PharmExec, 08/07/09 Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval
Cell Therapeutics, 08/07/09
Free full text
Prasugrel: The newest platelet inhibitor has arrived
American Pharmacists Association, 08/06/09
Free full text
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Wyeth, 08/06/09
Free full text
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 25 MG and 50 MG
Watson Pharmaceuticals, 08/05/09
Free full text
CryoLife Receives CE Mark Approval for BioFoam Hemostatic Technology
Cryolife, 08/05/09
Free full text
Cerner Mammography Gets FDA OK
HealthDataManagement, 08/05/09 FDA Approves Avastin for the Most Common Type of Kidney Cancer
Genentech, 08/04/09
Free full text
U.s. food and drug administration approves onglyza (saxagliptin) for the treatment of type 2 diabetes mellitus in adults
AstraZeneca, 08/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
